Pharmaceutical

EU Health Data Space strikes a chord in EU harmonisatio...

EU member states are set to launch the EU Health Data Space Regulation for harmo...

Unmatched quality in pharmaceutical logistics: Why it m...

Ensuring the highest standards in pharmaceutical logistics is crucial for patien...

FDA approves GSK’s Blujepa for uncomplicated UTIs

The FDA has approved GSK’s Blujepa for treating uncomplicated urinary tract infe...

Big pharma faces headwinds in China as vaccine sales de...

Multinational companies in China’s vaccine market face headwinds amid an anti-co...

Valneva outlays 40,000 vaccines to Réunion amidst chiku...

Valneva will work with local health authorities and wholesalers on the French is...

Alberta partners Siemens and the Alberta Cancer Foundation

The government of Alberta has announced a collaboration with Siemens Healthineer...

Rising Sirturo resistance highlights urgent need for ne...

Today marks World TB Day 2025 with the WHO calling for more investment into TB t...

Augustine secures $85m to advance Charcot-Marie-Tooth c...

Augustine Therapeutics has raised €78m ($85m) in funding to support the developm...

FDA approves IND application for Everest’s cancer vaccine

The FDA has granted approval for the IND application of Everest Medicines’ tumou...

AstraZeneca to invest $2.5bn in R&D centre in China

AstraZeneca has announced a $2.5bn investment to establish the company’s sixth w...

J&J boosts US operations with $55bn investment

J&J is the latest pharma company to announce a major US investment, committing t...

Alnylam challenges Pfizer and BridgeBio with FDA nod fo...

Amvuttra is now approved in the US to treat both cardiomyopathy and polyneuropat...

Sermonix and Regor to enhance breast cancer treatment o...

Sermonix Pharmaceuticals and Regor have announced a strategic partnership aimed ...

Tempero secures $70m to advance addiction treatment can...

TMP-301 is being investigated in clinical trials for alcohol use disorder and co...

China conditionally approves Hutchmed’s Tazverik for fo...

NMPA has granted conditional approval for Hutchmed’s Tazverik to treat adults wi...